Hyperliquid Strategies Inc and Sonnet BioTherapeutics Holdings, Inc. Announce Closing of Business Combination
Trading on The Nasdaq Capital Market under the ticker symbol “PURR”
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 03/30/20 | UPLOAD | SEC-generated letter |
|
1 | |
| 03/27/20 | 8-K | Current report filing |
|
3 | |
| 03/26/20 | 8-K | Current report filing |
|
3 | |
| 03/24/20 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 03/24/20 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 03/24/20 | S-3 | Registration statement for specified transactions by certain issuers |
|
22 | |
| 03/19/20 | 8-K | Current report filing |
|
5 | |
| 03/19/20 | 425 | Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions |
|
5 | |
| 03/19/20 | 10-K | Annual report pursuant to Section 13 and 15(d) |
|
   |
90 |
| 03/09/20 | 8-K | Current report filing |
|
3 |
